Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Microbial Metabolism Shifts Towards an Adverse Profile with Supplementary Iron in the TIM-2 In vitro Model of the Human Colon.

Kortman GA, Dutilh BE, Maathuis AJ, Engelke UF, Boekhorst J, Keegan KP, Nielsen FG, Betley J, Weir JC, Kingsbury Z, Kluijtmans LA, Swinkels DW, Venema K, Tjalsma H.

Front Microbiol. 2016 Jan 6;6:1481. doi: 10.3389/fmicb.2015.01481. eCollection 2015.

2.

Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.

Butt J, Romero-Hernández B, Pérez-Gómez B, Willhauck-Fleckenstein M, Holzinger D, Martin V, Moreno V, Linares C, Dierssen-Sotos T, Barricarte A, Tardón A, Altzibar JM, Moreno-Osset E, Franco F, Requena RO, Huerta JM, Michel A, Waterboer T, Castaño-Vinyals G, Kogevinas M, Pollán M, Boleij A, de Sanjosé S, Del Campo R, Tjalsma H, Aragonés N, Pawlita M.

Int J Cancer. 2016 Apr 1;138(7):1670-9. doi: 10.1002/ijc.29914. Epub 2015 Nov 20.

3.

Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women.

Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB.

Blood. 2015 Oct 22;126(17):1981-9. doi: 10.1182/blood-2015-05-642223. Epub 2015 Aug 19.

4.

Low dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens.

Kortman GA, Mulder ML, Richters TJ, Shanmugam NK, Trebicka E, Boekhorst J, Timmerman HM, Roelofs R, Wiegerinck ET, Laarakkers CM, Swinkels DW, Bolhuis A, Cherayil BJ, Tjalsma H.

Eur J Immunol. 2015 Sep;45(9):2553-67. doi: 10.1002/eji.201545642. Epub 2015 Jun 23.

5.

In Ivorian school-age children, infection with hookworm does not reduce dietary iron absorption or systemic iron utilization, whereas afebrile Plasmodium falciparum infection reduces iron absorption by half.

Glinz D, Hurrell RF, Righetti AA, Zeder C, Adiossan LG, Tjalsma H, Utzinger J, Zimmermann MB, N'Goran EK, Wegmüller R.

Am J Clin Nutr. 2015 Mar;101(3):462-70. doi: 10.3945/ajcn.114.090175. Epub 2015 Feb 4.

PMID:
25733630
6.

Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.

Ryan E, Ryan JD, Russell J, Coughlan B, Tjalsma H, Swinkels DW, Stewart S, Crowe JP.

Acta Haematol. 2015;133(2):155-61. doi: 10.1159/000363490. Epub 2014 Sep 26.

PMID:
25277871
7.

The aetiology of anaemia during pregnancy: a study to evaluate the contribution of iron deficiency and common infections in pregnant Ugandan women.

Baingana RK, Enyaru JK, Tjalsma H, Swinkels DW, Davidsson L.

Public Health Nutr. 2015 Jun;18(8):1423-35. doi: 10.1017/S1368980014001888. Epub 2014 Sep 15.

PMID:
25222882
8.

Nutritional iron turned inside out: intestinal stress from a gut microbial perspective.

Kortman GA, Raffatellu M, Swinkels DW, Tjalsma H.

FEMS Microbiol Rev. 2014 Nov;38(6):1202-34. doi: 10.1111/1574-6976.12086. Epub 2014 Sep 29. Review.

9.

Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants.

Jaeggi T, Kortman GA, Moretti D, Chassard C, Holding P, Dostal A, Boekhorst J, Timmerman HM, Swinkels DW, Tjalsma H, Njenga J, Mwangi A, Kvalsvig J, Lacroix C, Zimmermann MB.

Gut. 2015 May;64(5):731-42. doi: 10.1136/gutjnl-2014-307720. Epub 2014 Aug 20.

PMID:
25143342
10.

Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5-3 y.

Uijterschout L, Swinkels DW, Domellöf M, Lagerqvist C, Hudig C, Tjalsma H, Vos R, van Goudoever JB, Brus F.

Pediatr Res. 2014 Oct;76(4):409-14. doi: 10.1038/pr.2014.109. Epub 2014 Aug 12.

PMID:
25116229
11.

Conventional and novel peripheral blood iron markers compared against bone marrow in Malawian children.

Jonker FA, Boele van Hensbroek M, Leenstra T, Vet RJ, Brabin BJ, Maseko N, Gushu MB, Emana M, Kraaijenhagen R, Tjalsma H, Swinkels DW, Calis JC.

J Clin Pathol. 2014 Aug;67(8):717-23. doi: 10.1136/jclinpath-2014-202291. Epub 2014 Jun 10.

PMID:
24915849
12.

The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis.

Uijterschout L, Swinkels DW, Akkermans MD, Zandstra T, Nuijsink M, Hendriks D, Hudig C, Tjalsma H, Vos R, van Goudoever JB, Brus F.

J Cyst Fibros. 2014 Dec;13(6):639-44. doi: 10.1016/j.jcf.2014.03.007. Epub 2014 Apr 13.

13.

A seven day running training period increases basal urinary hepcidin levels as compared to cycling.

Sim M, Dawson B, Landers GJ, Swinkels DW, Tjalsma H, Wiegerinck ET, Trinder D, Peeling P.

J Int Soc Sports Nutr. 2014 Apr 9;11(1):14. doi: 10.1186/1550-2783-11-14.

14.

Engineered human lipocalin as an antibody mimetic: application to analysis of the small peptide hormone hepcidin.

Grebenchtchikov N, Geurts-Moespot AJ, Trentmann S, Andersen N, Bel Aiba RS, Allersdorfer A, Laarakkers CM, Sweep FC, Tjalsma H, Hohlbaum AM, Swinkels DW.

Clin Chem. 2014 Jun;60(6):897-9. doi: 10.1373/clinchem.2014.221671. Epub 2014 Apr 7. No abstract available.

15.

Influence of post-exercise hypoxic exposure on hepcidin response in athletes.

Badenhorst CE, Dawson B, Goodman C, Sim M, Cox GR, Gore CJ, Tjalsma H, Swinkels DW, Peeling P.

Eur J Appl Physiol. 2014 May;114(5):951-9. doi: 10.1007/s00421-014-2829-6. Epub 2014 Feb 1.

PMID:
24487960
16.

Iron-induced virulence of Salmonella enterica serovar typhimurium at the intestinal epithelial interface can be suppressed by carvacrol.

Kortman GA, Roelofs RW, Swinkels DW, de Jonge MI, Burt SA, Tjalsma H.

Antimicrob Agents Chemother. 2014;58(3):1664-70. doi: 10.1128/AAC.02060-13. Epub 2013 Dec 30.

17.

Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females.

Sim M, Dawson B, Landers G, Swinkels DW, Tjalsma H, Yeap BB, Trinder D, Peeling P.

J Sci Med Sport. 2015 Jan;18(1):8-12. doi: 10.1016/j.jsams.2013.11.008. Epub 2013 Nov 28.

PMID:
24373771
18.

Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency.

Jonker FA, Calis JC, Phiri K, Kraaijenhagen RJ, Brabin BJ, Faragher B, Wiegerinck ET, Tjalsma H, Swinkels DW, van Hensbroek MB.

PLoS One. 2013 Dec 5;8(12):e78964. doi: 10.1371/journal.pone.0078964. eCollection 2013.

19.

Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform.

Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, Tjalsma H, Swinkels DW.

PLoS One. 2013 Oct 4;8(10):e75518. doi: 10.1371/journal.pone.0075518. eCollection 2013.

20.

Is colonoscopy necessary in cases of infection by Streptococcus bovis biotype II?

Corredoira JC, Alonso MP, García-País MJ, Rabuñal R, García-Garrote F, López-Roses L, Lancho A, Coira A, Pita J, Velasco D, López-Álvarez MJ, Tjalsma H, Varela J.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):171-7. doi: 10.1007/s10096-013-1940-7. Epub 2013 Aug 11.

PMID:
23934596
21.

The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.

Boleij A, Tjalsma H.

Lancet Infect Dis. 2013 Aug;13(8):719-24. doi: 10.1016/S1473-3099(13)70107-5. Epub 2013 Jul 5.

PMID:
23831427
22.

Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.

Goetze O, Schmitt J, Spliethoff K, Theurl I, Weiss G, Swinkels DW, Tjalsma H, Maggiorini M, Krayenbühl P, Rau M, Fruehauf H, Wojtal KA, Müllhaupt B, Fried M, Gassmann M, Lutz T, Geier A.

Hepatology. 2013 Dec;58(6):2153-62. doi: 10.1002/hep.26581. Epub 2013 Oct 11.

PMID:
23787477
23.

Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer.

Dutilh BE, Backus L, van Hijum SA, Tjalsma H.

Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):85-99. doi: 10.1016/j.bpg.2013.03.008. Review.

PMID:
23768555
24.

Iron supplementation in suckling piglets: how to correct iron deficiency anemia without affecting plasma hepcidin levels.

Starzyński RR, Laarakkers CM, Tjalsma H, Swinkels DW, Pieszka M, Styś A, Mickiewicz M, Lipiński P.

PLoS One. 2013 May 30;8(5):e64022. doi: 10.1371/journal.pone.0064022. Print 2013.

25.

Iron metabolism in the pathogenesis of iron-induced kidney injury.

Martines AM, Masereeuw R, Tjalsma H, Hoenderop JG, Wetzels JF, Swinkels DW.

Nat Rev Nephrol. 2013 Jul;9(7):385-98. doi: 10.1038/nrneph.2013.98. Epub 2013 May 14. Review.

PMID:
23670084
26.

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

Tisi MC, Bozzoli V, Giachelia M, Massini G, Ricerca BM, Maiolo E, D'Alo' F, Larocca LM, Piciocchi A, Tjalsma H, Swinkels DW, Voso MT, Leone G, Hohaus S.

Leuk Lymphoma. 2014 Feb;55(2):270-5. doi: 10.3109/10428194.2013.802314. Epub 2013 Jun 12.

PMID:
23647063
27.

Iron status and systemic inflammation, but not gut inflammation, strongly predict gender-specific concentrations of serum hepcidin in infants in rural Kenya.

Jaeggi T, Moretti D, Kvalsvig J, Holding PA, Tjalsma H, Kortman GA, Joosten I, Mwangi A, Zimmermann MB.

PLoS One. 2013;8(2):e57513. doi: 10.1371/journal.pone.0057513. Epub 2013 Feb 27.

28.

Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk.

Kato I, Boleij A, Kortman GA, Roelofs R, Djuric Z, Severson RK, Tjalsma H.

Nutr Cancer. 2013;65(2):169-77. doi: 10.1080/01635581.2013.748922.

29.

Diurnal rhythm rather than dietary iron mediates daily hepcidin variations.

Schaap CC, Hendriks JC, Kortman GA, Klaver SM, Kroot JJ, Laarakkers CM, Wiegerinck ET, Tjalsma H, Janssen MC, Swinkels DW.

Clin Chem. 2013 Mar;59(3):527-35. doi: 10.1373/clinchem.2012.194977. Epub 2012 Dec 11.

30.

Effect of exercise modality and intensity on post-exercise interleukin-6 and hepcidin levels.

Sim M, Dawson B, Landers G, Swinkels DW, Tjalsma H, Trinder D, Peeling P.

Int J Sport Nutr Exerc Metab. 2013 Apr;23(2):178-86. Epub 2012 Oct 11.

PMID:
23070801
31.

Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention.

Baumgartner J, Smuts CM, Aeberli I, Malan L, Tjalsma H, Zimmermann MB.

Int J Obes (Lond). 2013 Jan;37(1):24-30. doi: 10.1038/ijo.2012.145. Epub 2012 Sep 4.

PMID:
22945607
32.

Second round robin for plasma hepcidin methods: first steps toward harmonization.

Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW.

Am J Hematol. 2012 Oct;87(10):977-83. doi: 10.1002/ajh.23289. Epub 2012 Aug 7.

33.

A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Tjalsma H, Boleij A, Marchesi JR, Dutilh BE.

Nat Rev Microbiol. 2012 Jun 25;10(8):575-82. doi: 10.1038/nrmicro2819. Review.

PMID:
22728587
34.

Bacterial responses to a simulated colon tumor microenvironment.

Boleij A, Dutilh BE, Kortman GA, Roelofs R, Laarakkers CM, Engelke UF, Tjalsma H.

Mol Cell Proteomics. 2012 Oct;11(10):851-62. Epub 2012 Jun 19.

35.

The effects of acute exercise bouts on hepcidin in women.

Newlin MK, Williams S, McNamara T, Tjalsma H, Swinkels DW, Haymes EM.

Int J Sport Nutr Exerc Metab. 2012 Apr;22(2):79-88. Epub 2012 Feb 15.

PMID:
22349362
36.
37.

Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer.

Boleij A, Tjalsma H.

Biol Rev Camb Philos Soc. 2012 Aug;87(3):701-30. doi: 10.1111/j.1469-185X.2012.00218.x. Epub 2012 Feb 2. Review.

PMID:
22296522
38.

Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface.

Kortman GA, Boleij A, Swinkels DW, Tjalsma H.

PLoS One. 2012;7(1):e29968. doi: 10.1371/journal.pone.0029968. Epub 2012 Jan 17.

39.

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.

Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, Manzia TM, Angelico R, Swinkels DW, Tjalsma H, López M, Abraldes JG, Bonaccorsi-Riani E, Jaeckel E, Taubert R, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A.

J Clin Invest. 2012 Jan;122(1):368-82. doi: 10.1172/JCI59411. Epub 2011 Dec 12.

40.

Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients.

Boleij A, Roelofs R, Danne C, Bellais S, Dramsi S, Kato I, Tjalsma H.

Cancer Prev Res (Phila). 2012 Feb;5(2):260-5. doi: 10.1158/1940-6207.CAPR-11-0321. Epub 2011 Oct 19.

41.

Hepcidin in human iron disorders: diagnostic implications.

Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW.

Clin Chem. 2011 Dec;57(12):1650-69. doi: 10.1373/clinchem.2009.140053. Epub 2011 Oct 11. Review.

42.

Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.

Boleij A, van Gelder MM, Swinkels DW, Tjalsma H.

Clin Infect Dis. 2011 Nov;53(9):870-8. doi: 10.1093/cid/cir609. Epub 2011 Sep 29. Review.

PMID:
21960713
43.

Surface-affinity profiling to identify host-pathogen interactions.

Boleij A, Laarakkers CM, Gloerich J, Swinkels DW, Tjalsma H.

Infect Immun. 2011 Dec;79(12):4777-83. doi: 10.1128/IAI.05572-11. Epub 2011 Sep 26.

44.

Towards the human colorectal cancer microbiome.

Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, Tjalsma H.

PLoS One. 2011;6(5):e20447. doi: 10.1371/journal.pone.0020447. Epub 2011 May 24.

45.

Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer.

Boleij A, Muytjens CM, Bukhari SI, Cayet N, Glaser P, Hermans PW, Swinkels DW, Bolhuis A, Tjalsma H.

J Infect Dis. 2011 Apr 15;203(8):1101-9. doi: 10.1093/infdis/jiq169.

PMID:
21451000
46.

Mass spectrometry analysis of hepcidin peptides in experimental mouse models.

Tjalsma H, Laarakkers CM, van Swelm RP, Theurl M, Theurl I, Kemna EH, van der Burgt YE, Venselaar H, Dutilh BE, Russel FG, Weiss G, Masereeuw R, Fleming RE, Swinkels DW.

PLoS One. 2011 Mar 8;6(3):e16762. doi: 10.1371/journal.pone.0016762.

47.

Identification of biomarkers for colorectal cancer through proteomics-based approaches.

Tjalsma H.

Expert Rev Proteomics. 2010 Dec;7(6):879-95. doi: 10.1586/epr.10.81. Review.

PMID:
21142889
48.

Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Cercamondi CI, Egli IM, Ahouandjinou E, Dossa R, Zeder C, Salami L, Tjalsma H, Wiegerinck E, Tanno T, Hurrell RF, Hounhouigan J, Zimmermann MB.

Am J Clin Nutr. 2010 Dec;92(6):1385-92. doi: 10.3945/ajcn.2010.30051. Epub 2010 Oct 6. Erratum in: Am J Clin Nutr. 2015 Apr;101(4):894.

49.

Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.

Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, Peters HP, van Dongen-Lases E, Wetzels JF, Sweep FC, Tjalsma H, Swinkels DW.

Clin Chem. 2010 Oct;56(10):1570-9. doi: 10.1373/clinchem.2010.149187. Epub 2010 Aug 25.

50.

Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients.

Boleij A, Roelofs R, Schaeps RM, Schülin T, Glaser P, Swinkels DW, Kato I, Tjalsma H.

Cancer. 2010 Sep 1;116(17):4014-22. doi: 10.1002/cncr.25212.

Supplemental Content

Loading ...
Support Center